IL5 and chronic obstructive pulmonary disease: Therefore, in exacerbations of COPD where eosinophils are identified and steroid26 or anti–IL-5 eosinophil-targeting27,28 therapies are considered, the addition of future novel antiviral therapies may be of particular benefit.